Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
January 18, 2023: FDA and HHS/ASPR authorized an additional extension to the shelf-life from 18 months to 24 months for the Pfizer antiviral therapy, Paxlovid (nirmatrelvir tablets and ritonavir tablets co-packaged for oral use)
Internal Medicine Internal Medicine physician with 30+ years focused on metabolic health, nutrition, and deficiency management
IV drip flu therapy is generally appropriate for: Adults ages 18 and older who are experiencing flu symptoms Individuals with moderate to severe dehydration from fever or reduced fluid intake People unable to keep oral fluids down due to nausea or vomiting Those with significant fatigue, body aches, or headaches from flu Individuals looking to reduce recovery time from flu People with autoimmune conditions who may experience more severe flu symptoms Those at higher risk for flu complications who want to support recovery Possible Risks & How They're Managed While IV drip flu therapy is generally very safe, there are some potential risks: Infection : Though rare, infection at the IV site is possible
Machine Learning in Analytical Chemistry Emerging machine learning (ML) tools process thousands of spectra and chromatograms to identify subtle trends humans might miss
US$ 27.47
US$ 20.16
US$ 21.37
US$ 23.54
US$ 25.66
US$ 27.97
US$ 21.92
US$ 29.86
